期刊文献+

持续肾脏替代疗法治疗脓毒性休克并多器官功能不全16例 被引量:1

Effect of Continuous Renal Replacement Therapy on 16 Children with Septic Shock Complicated with Multiple Organ Dysfunction
下载PDF
导出
摘要 目的评价持续肾脏替代疗法(CRRT)在脓毒性休克并多器官功能不全综合征(MODS)中的治疗作用。方法应用CRRT治疗脓毒性休克并MODS患儿16例,评价CRRT治疗后12、36 h血压、心率、射血分数(EF)、C反应蛋白(CRP)、pH、氧合指数[Pa(O2)/FiO2]、钠、钾、BUN、Cr、IL-8的变化。结果治疗后12、36 h血压、心率、EF值、pH、Pa(O2)/FiO2、CRP、钠、钾、BUN、Cr、IL-8与治疗前比较差异均有显著性意义(Pa<0.05)。治疗后36 hPa(O2)/FiO2、IL-8、CRP、钠、BUN、Cr与治疗12 h比较,差异均有显著性(Pa<0.05)。余指标亦较治疗12 h改善,但差异无显著性(Pa>0.05)。结论CRRT可改善儿童脓毒性休克并MODS的脏器功能,改善水、电解质、酸碱平衡,为脓毒性休克并MODS治疗提供又一措施。 Objective To study the effect of continuous renal replacement therapy(CRRT) on septic shock complicated with multiple organ dysfunction syndrome(MODS). Methods Sixteen cases with septic shock and MODS were treated by CRRT. Blood presure, heart rate, ejection fraction (EF) , C - react protein (CRP) , pH, Pa ( O2 )/FiO2, Na^+ , K^+ , BUN, Cr, interleukin - 8 ( IL - 8 ) were determined before CRRT and 12,36 h after CRRT. Results Blood presure,heart rate,EF,pH,Pa(O2 )/FiO2 ,CRP,Na^+ ,K^+ ,BUN,Cr,IL -8 in children with MODS before CRRT were significantly different compared with those before CRRT and 12,36 h after CRRT( Pa 〈 0.05 ), And Pa(O2)/FiO2, IL - 8, CRP, Na^+ , BUN, Cr were significantly different from those of 12 h after CRRT ( Pa 〈 0, 05 ) ; the others had no satistical significance ( Pa 〉 0.05 ). Conclusions CRRT may improve organ function, balance of water, electrolyte,acid - alkaii in septic shock and MODS. CRRT is an useful tool in the treatment of septic shock and MODS.
作者 韩国强
出处 《实用儿科临床杂志》 CAS CSCD 北大核心 2007年第6期441-442,共2页 Journal of Applied Clinical Pediatrics
关键词 持续肾脏替代疗法 休克 脓毒性 多器官功能衰竭 呼吸窘迫综合征 persistent renal replacement therapy septic shock multiple organ failure synodrome respiratory distress syndrome
  • 相关文献

参考文献8

二级参考文献73

  • 1王士雯.老年多器官功能不全综合征的肺启动机制[J].中华老年多器官疾病杂志,2002,1(1):4-6. 被引量:113
  • 2陈贤楠,沈颖.血液净化疗法对多器官功能障碍综合征的治疗作用[J].中国实用儿科杂志,2004,19(9):513-515. 被引量:11
  • 3中华医学会呼吸病学分会.急性肺损伤/急性呼吸窘迫综合征的诊断标准(草案)[J].中华结核和呼吸杂志,2000,23(4):203-203. 被引量:479
  • 4[2]Sobotova D,Zharfbin A,Svojanovsky J,et al.Hypertension in hemodialyzed uremic patients[J].Vnitr Lek,1999,45(11):641-644. 被引量:1
  • 5[3]London G M,Parfrey P S.Cardiac disease in chronic uremia:pathogenesis[J].Adv Ren Replace Ther,1997,4(3):194-211. 被引量:1
  • 6[4]Meeus F,Kourilsky O,Guerin A P,et al.Pathophysiology of cardiovascular disease in hemodialysis patients[J].Kidney Int Suppl,2000,76:S140-147. 被引量:1
  • 7[5]Stenvinkel P.Inflammatory and atherosclerotic interactions in the depleteduremic patient[J].Blood Purif,2001,19(1):53-61. 被引量:1
  • 8[6]Ronco C,Bellom R.Continuous renal replacement therapy:Evolution intechnology and current nomenclature [J].Kidney Int,1998,53(Suppl166):160-165. 被引量:1
  • 9[7]Van Bommel E,Bouvy N D,So K L,et al.Acute dialytic support for thecritically ill:Intermittent HD versus continuous arteriovenous hemodiafiltration[J].Am J Nephrol,1995,15(3):192. 被引量:1
  • 10[1]American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis[J]. Crit Care Med,1992,20:864 - 874. 被引量:1

共引文献73

同被引文献5

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部